Sökresultat - "FIB‐4"

Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis

Saidi, A. N.^{Aff1, Aff2, IDs10067025073645_cor1}, Theel, W. B.^{Aff1, Aff2, Aff3}, Burggraaf, B., van der Lelij, A. J., Grobbee, D. E., van Zeben, J. D., van der Zwan-van Beek, E., Rauh, S. P., Cabezas, M. Castro^{Aff1, Aff2, Aff4, Aff5}

Impact of the Underutilization of Vibration-Controlled Transient Elastography in MASLD Patients Without Insurance Coverage

Ma, Christopher, Goldberg, David S.^{Aff2, Aff3, IDs10620025089922_cor1}

Clinical Significance of Fibrosis 4 Index in Early-stage Hepatocellular Carcinoma Patients Received Ultrasound-guided Microwave Ablation

Chen, Jun^Aff1, Jiang, Xiao^Aff2, Chen, Yunbao, Tang, Hongtao, Zhang, Ye^{Aff3, IDs1201002405108w_cor1}, Lu, Yanyan^{Aff4, IDs1201002405108w_cor2}

Improving Recurrence Prediction in Intrahepatic Cholangiocarcinoma: The Synergistic Impact of the FIB-4 Index and Tumor Burden Score on Post-hepatectomy Outcomes

Akabane, Miho, Kawashima, Jun, Woldesenbet, Selamawit, Macedo, Amanda B., Cauchy, François, Shen, Feng, Maithel, Shishir K., Groot Koerkamp, Bas, Alexandrescu, Sorin, Kitago, Minoru, Weiss, Matthew, Martel, Guillaume, Pulitano, Carlo, Aldrighetti, Luca, Poultsides, George A., Imaoka, Yuki, Guglielmi, Alfredo, Bauer, Todd W., Endo, Itaru, Gleisner, Ana, Marques, Hugo P., Pawlik, Timothy M.^{Aff1, Aff18, IDs10434024164557_cor1}

Association between liver fibrosis and osteoporosis in adults aged 50 and older: insights from the Bushehr Elderly Health Program

Soltani, Azin^{Aff1, Aff2}, Aghakhani, Amirhossein, Dehghanbanadaki, Hojat, Majidi, Ziba, Rezaei-Tavirani, Mostafa, Shafiee, Gita, Ostovar, Afshin, Mir Moeini, Seyed Amirhossein, Bandarian, Fatemeh, Larijani, Bagher, Nabipour, Iraj, Fahimfar, Noushin^{Aff1, Aff3, IDs4020002501574z_cor1}, Razi, Farideh^{Aff1, IDs4020002501574z_cor2}

Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes

Hiroyuki Ito, Ryota Someya, Tomoko Koyanagi, Chiaki I, Shun Miura, Suzuko Matsumoto, Hideyuki Inoue, Shinichi Antoku, Tomoko Yamasaki, Toshiko Mori, Michiko Togane

electronic resource

Visa; Visa

Metabolic dysfunction in patients following DAA-induced viral cure for HCV infection: A non-negligible risk to liver-related health: Editorial on 'Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C'

Chen-Hua Liu, Yu-Ping Chang

electronic resource

Visa; Visa; Visa

Association between fibrosis-4 index (FIB-4) and gallstones: an analysis of the NHANES 2017–2020 cross-sectional study

Huqiang Dong, Zufa Zhang, Chang Fu, Mixue Guo, Haifeng Zhang, Xintian Cai, Hongping Cheng

electronic resource

Visa

Utility of Quantitative Assessment of Tc-99m-diethylenetriamine-penta-acetic acid-galactosyl Human Serum Albumin SPECT/CT in the Identification of Severe Liver Fibrosis: Its Complementary Diagnostic Value with Other Liver Function Indices

Kozaki, Yoichi, Ichikawa, Yasutaka^{Aff1, IDs11307024019582_cor1}, Nakamura, Satoshi, Kobayashi, Tatsuhiro, Tomita, Yoya, Nagata, Motonori, Kuriyama, Naohisa, Mizuno, Shugo, Sakuma, Hajime

Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Type 2 Diabetes Mellitus

Hilmi Erdem Sümbül, Tayyibe Saler, Ahmet Gazi Mustan, Cahit Dincer, İrfan Alişan, Bercem Berent Kaya, Mehmet Can Erişen, Bektaş Işık, Begüm Şeyda Avci, Fatih Necip Arici, Dilan Damla Ozturk, Erdinc Gulumsek, Hüseyin Ali Öztürk

electronic resource

Visa; Visa

Diagnostic value of serologic biomarkers for the detection of liver fibrosis in non-alcoholic fatty liver disease

Mahsa Mohammadi, Keyvan Aminian, Farahnaz Joukar, Mohsen Rajabnia, Khaled Rahmani, Alireza Doostian, Fariborz Mansour-Ghanaei

electronic resource

Visa; Visa; Visa

FAN score predicts prognosis after platinum-based first-line chemotherapy in patients with metastatic urothelial carcinoma

Yu Ishizuya, Atsunari Kawashima, Yuki Horibe, Akinaru Yamamoto, Masaru Tani, Akihiro Yoshimura, Liu Yutong, Sassi Nesrine, Toshiki Oka, Yohei Okuda, Toshihiro Uemura, Gaku Yamamichi, Takuji Hayashi, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Norio Nonomura

electronic resource

Visa

Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients

Mohamed El-Kassas, Wafaa Elakel, Aisha Elsharkawy, Noha Asem, Ahmed Abu-Elfatth, Aya Mostafa, Amr Abdelazeem, Magdy El-Serafy, Mohamed Ibrahem, Eman Alsayed Ghanem, Nermeen Abdeen, Wahid Doss, Gamal Esmat, Doaa Abdeltawab

electronic resource

Visa

Association between fibrosis‐4 index and cognitive impairment in elderly patients with hypertension: A cross‐sectional study

Hong Ding, Jingtao Wang, Shu Liu, Yafei Xie, Xiaowei Zhang, Jing Yu

electronic resource

Visa; Visa

Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice

Lazarus, Jeffrey V, Castera, Laurent, Mark, Henry E, Allen, Alina M, Adams, Leon A, Anstee, Quentin M, Arrese, Marco, Alqahtani, Saleh A, Bugianesi, Elisabetta, Colombo, Massimo, Cusi, Kenneth, Hagström, Hannes, Loomba, Rohit, Romero-Gómez, Manuel, Schattenberg, Jörn M, Thiele, Maja, Valenti, Luca, Wong, Vincent Wai-Sun, Yilmaz, Yusuf, Younossi, Zobair M, Francque, Sven M, Tsochatzis, Emmanuel A

application/pdf

Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK)

Zobair M. Younossi, James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, Fatema Nader

electronic resource

Visa; Visa

Early screening for chronic liver disease: impact of a FIB-4 first integrated care pathway to identify patients with significant fibrosis

Mignot, V., Chirica, C., Tron, L., Borowik, A., Borel, A. L., Rostaing, L., Bouillet, L., Decaens, T., Guergour, D., Costentin, C. E.^{Aff1, Aff6, IDs4159802466210x_cor10}

Serum dithiothreitol-oxidizing capacity (DOC) is a promising biomarker for excluding significant liver fibrosis: a proof-of-concept study

Yang, Lumin, Zhang, Yafei, Hong, Xiaodan, Zhang, Ke, Liu, Bingyan, Zhang, Peixin, Tang, Qianqian, Yu, Jian, Jin, Xiao-Zhi, Jin, Xin-Zhe, Zhang, Ni, Targher, Giovanni^{Aff5, Aff6}, Byrne, Christopher D., Zhang, Zhenhua^{Aff2, IDs1291602403502z_cor14}, Zheng, Ming-Hua^{Aff3, Aff8, IDs1291602403502z_cor15}, Zhang, Jinsong^{Aff1, IDs1291602403502z_cor16}

ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma

Tian, Yi-Bo^{Aff1, Aff2}, Niu, Hong, Xu, Feng^{Aff4, IDs41598024582055_cor3}, Shang-Guan, Peng-Wei, Song, Wei-Wei

Evaluation of soluble suppression of tumorigenicity 2 (sST2) as serum marker for liver fibrosis

Hildenbrand, Florian F.^{Aff1, Aff2}, Illi, Barbara, von Felten, Stefanie, Bachofner, Jacqueline, Gawinecka, Joanna, von Eckardstein, Arnold, Müllhaupt, Beat, Mertens, Joachim C., Blümel, Sena^{Aff1, IDs12876023031164_cor9}